Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.

Ozawa T, Afzal J, Lamborn KR, Bollen AW, Bauer WF, Koo MS, Kahl SB, Deen DF.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):247-52.

PMID:
16111595
2.

In vivo evaluation of the boronated porphyrin TABP-1 in U-87 MG intracerebral human glioblastoma xenografts.

Ozawa T, Santos RA, Lamborn KR, Bauer WF, Koo MS, Kahl SB, Deen DF.

Mol Pharm. 2004 Sep-Oct;1(5):368-74.

PMID:
16026007
3.

Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo--a new possibility in boron neutron capture therapy.

Ceberg CP, Brun A, Mir LM, Persson BR, Salford LG.

Anticancer Drugs. 1994 Aug;5(4):463-6.

PMID:
7949252
4.

Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.

Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH, Joel DD, Nawrocky MM, Ono K, Goodman JH.

Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):209-18.

PMID:
10758326
5.

Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.

Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH.

J Neurooncol. 1997 May;33(1-2):59-70.

PMID:
9151224
6.

Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.

Barth RF, Yang W, Adams DM, Rotaru JH, Shukla S, Sekido M, Tjarks W, Fenstermaker RA, Ciesielski M, Nawrocky MM, Coderre JA.

Cancer Res. 2002 Jun 1;62(11):3159-66.

7.

Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.

Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.

Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):663-72.

PMID:
9112465
8.

Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine.

Yang W, Barth RF, Bartus RT, Rotaru JH, Moeschberger ML, Ferketich AK, Nawrocky MM, Coderre JA, Goodman JH.

Neurosurgery. 2000 Jul;47(1):189-97; discussion 197-8.

PMID:
10917362
9.
10.

Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.

Barth RF, Grecula JC, Yang W, Rotaru JH, Nawrocky M, Gupta N, Albertson BJ, Ferketich AK, Moeschberger ML, Coderre JA, Rofstad EK.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):267-77.

PMID:
14697448
11.
12.

Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.

Barth RF, Yang W, Al-Madhoun AS, Johnsamuel J, Byun Y, Chandra S, Smith DR, Tjarks W, Eriksson S.

Cancer Res. 2004 Sep 1;64(17):6287-95.

13.

Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP.

Viaggi M, Dagrosa MA, Longhino J, Blaumann H, Calzetta O, Kahl SB, Juvenal GJ, Pisarev MA.

Appl Radiat Isot. 2004 Nov;61(5):905-9.

PMID:
15308166
14.

Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.

Yang W, Barth RF, Wu G, Bandyopadhyaya AK, Thirumamagal BT, Tjarks W, Binns PJ, Riley K, Patel H, Coderre JA, Ciesielski MJ, Fenstermaker RA.

Appl Radiat Isot. 2004 Nov;61(5):981-5.

PMID:
15308179
15.

Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.

Yang W, Barth RF, Wu G, Kawabata S, Sferra TJ, Bandyopadhyaya AK, Tjarks W, Ferketich AK, Moeschberger ML, Binns PJ, Riley KJ, Coderre JA, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ.

Clin Cancer Res. 2006 Jun 15;12(12):3792-802.

16.

Long-term infusions of p-boronophenylalanine for boron neutron capture therapy: evaluation using rat brain tumor and spinal cord models.

Morris GM, Micca PL, Nawrocky MM, Weissfloch LE, Coderre JA.

Radiat Res. 2002 Dec;158(6):743-52.

PMID:
12452777
17.

Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.

Dagrosa MA, Viaggi M, Rebagliati RJ, Batistoni D, Kahl SB, Juvenal GJ, Pisarev MA.

Mol Pharm. 2005 Mar-Apr;2(2):151-6.

PMID:
15804189
18.

Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7).

Barth RF, Yang W, Bartus RT, Moeschberger ML, Goodman JH.

Neurosurgery. 1999 Feb;44(2):351-9; discussion 359-60.

PMID:
9932889
19.

Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.

Yang W, Barth RF, Carpenter DE, Moeschberger ML, Goodman JH.

Neurosurgery. 1996 May;38(5):985-92.

PMID:
8727825
20.

Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.

Schinazi RF, Hurwitz SJ, Liberman I, Juodawlkis AS, Tharnish P, Shi J, Liotta DC, Coderre JA, Olson J.

Clin Cancer Res. 2000 Feb;6(2):725-30.

Supplemental Content

Support Center